IP Library › Granted Patent US 8,088,390
Granted Patent B2
US 8,088,390 · App. 11/973,468 · Granted Jan 3, 2012

Methods for the early diagnosis of ovarian cancer

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,088,390
App. No.
11/973,468
Granted
Jan 3, 2012
Kind
B2
Abstract

The present invention discloses the protease stratum corneum chymotryptic enzyme (SCCE) is specifically over-expressed in ovarian and other malignancies. A number of SCCE peptides can induce immune responses to SCCE, thereby demonstrating the potential of these peptides in monitoring and the development of immunotherapies for ovarian and other malignancies.

Claims (1)

1. An immunogenic composition, comprising an immunogenic fragment of a stratum corneum chymotryptic enzyme protein and an adjuvant, wherein said immunogenic fragment of a stratum corneum enzyme protein is a peptide consisting of the sequence selected from the group consisting of SEQ ID Nos. 31, 32, 33, 34, 35, 36, 80, 86 and 99.